The Active Compound Thymoquinone Alters Chondrogenic Differentiation of Human Mesenchymal Stem Cells via Modulation of Intracellular Signaling
Objective: The regenerative potential of mesenchymal stem cell (MSC)-like cells in the cartilage is relatively low because of the lack of innervation and vascularization. The increase in proinflammatory cytokines in cartilage damage can increase the expression of apoptotic and proinflammatory genes...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Galenos Publishing House
2022-03-01
|
| Series: | Medeniyet Medical Journal |
| Subjects: | |
| Online Access: | https://jag.journalagent.com/z4/download_fulltext.asp?pdir=medeniyet&un=MEDJ-68915 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832581992813690880 |
|---|---|
| author | Banu ISKENDER |
| author_facet | Banu ISKENDER |
| author_sort | Banu ISKENDER |
| collection | DOAJ |
| description | Objective: The regenerative potential of mesenchymal stem cell (MSC)-like cells in the cartilage is relatively low because of the lack of innervation and vascularization. The increase in proinflammatory cytokines in cartilage damage can increase the expression of apoptotic and proinflammatory genes and the matrix degradation enzymes via nuclear factor-κB (NF-κB). Previous evidence suggested that thymoquinone (TQ) suppresses tumor necrosis factor-α-mediated NF-κB activation in different cancer cell lines. The suppression of the NF-κB pathway increases chondrogenic differentiation by inhibiting osteogenic differentiation in MSCs. Therefore, the current descriptive study aimed at highlighting the role of thymoquinone on the differentiation of human MSCs (hMSCs) since it is predicted that agents with known anti-inflammatory properties such as TQ have the potential to alter the chondrogenic differentiation of MSCs.
Methods: In this study, the bioactive component thymoquinone, with its well-documented effects on the NF-κB signaling pathway, was used in hMSC differentiation assays. The effects of thymoquinone on hMSC differentiation and the relevant intracellular signaling pathways were determined using immunocytochemistry and western blotting for the first time. Changes in the phosphorylation status of some signaling components involved in NF-κB and mTOR signaling were also evaluated.
Results: The chondrogenic differentiation potential of hMSCs treated with TQ decreased, concomitant with the decrease in the activity of NF-κB signaling pathway components. Thymoquinone triggered the suppression of NF-κB signaling, which interfered with the chondrogenic potential of hMSC, as opposed to some previous findings in the literature.
Conclusions: The results of this study are of great importance for the optimization of directed differentiation of hMSCs and hMSC-mediated cellular therapies. |
| format | Article |
| id | doaj-art-e7dc038e1ab84a7397f7f31917a36cc0 |
| institution | Kabale University |
| issn | 2149-2042 2149-4606 |
| language | English |
| publishDate | 2022-03-01 |
| publisher | Galenos Publishing House |
| record_format | Article |
| series | Medeniyet Medical Journal |
| spelling | doaj-art-e7dc038e1ab84a7397f7f31917a36cc02025-01-30T07:15:46ZengGalenos Publishing HouseMedeniyet Medical Journal2149-20422149-46062022-03-0137111210.4274/MMJ.galenos.2022.68915MEDJ-68915The Active Compound Thymoquinone Alters Chondrogenic Differentiation of Human Mesenchymal Stem Cells via Modulation of Intracellular SignalingBanu ISKENDER0Kocaeli University Faculty of Medicine, Department of Medical Biology, Kocaeli, TurkeyObjective: The regenerative potential of mesenchymal stem cell (MSC)-like cells in the cartilage is relatively low because of the lack of innervation and vascularization. The increase in proinflammatory cytokines in cartilage damage can increase the expression of apoptotic and proinflammatory genes and the matrix degradation enzymes via nuclear factor-κB (NF-κB). Previous evidence suggested that thymoquinone (TQ) suppresses tumor necrosis factor-α-mediated NF-κB activation in different cancer cell lines. The suppression of the NF-κB pathway increases chondrogenic differentiation by inhibiting osteogenic differentiation in MSCs. Therefore, the current descriptive study aimed at highlighting the role of thymoquinone on the differentiation of human MSCs (hMSCs) since it is predicted that agents with known anti-inflammatory properties such as TQ have the potential to alter the chondrogenic differentiation of MSCs. Methods: In this study, the bioactive component thymoquinone, with its well-documented effects on the NF-κB signaling pathway, was used in hMSC differentiation assays. The effects of thymoquinone on hMSC differentiation and the relevant intracellular signaling pathways were determined using immunocytochemistry and western blotting for the first time. Changes in the phosphorylation status of some signaling components involved in NF-κB and mTOR signaling were also evaluated. Results: The chondrogenic differentiation potential of hMSCs treated with TQ decreased, concomitant with the decrease in the activity of NF-κB signaling pathway components. Thymoquinone triggered the suppression of NF-κB signaling, which interfered with the chondrogenic potential of hMSC, as opposed to some previous findings in the literature. Conclusions: The results of this study are of great importance for the optimization of directed differentiation of hMSCs and hMSC-mediated cellular therapies.https://jag.journalagent.com/z4/download_fulltext.asp?pdir=medeniyet&un=MEDJ-68915human mesenchymal stem cellsnf-κb signalling pathwaychondrogenic differentiationthymoquinone |
| spellingShingle | Banu ISKENDER The Active Compound Thymoquinone Alters Chondrogenic Differentiation of Human Mesenchymal Stem Cells via Modulation of Intracellular Signaling Medeniyet Medical Journal human mesenchymal stem cells nf-κ b signalling pathway chondrogenic differentiation thymoquinone |
| title | The Active Compound Thymoquinone Alters Chondrogenic Differentiation of Human Mesenchymal Stem Cells via Modulation of Intracellular Signaling |
| title_full | The Active Compound Thymoquinone Alters Chondrogenic Differentiation of Human Mesenchymal Stem Cells via Modulation of Intracellular Signaling |
| title_fullStr | The Active Compound Thymoquinone Alters Chondrogenic Differentiation of Human Mesenchymal Stem Cells via Modulation of Intracellular Signaling |
| title_full_unstemmed | The Active Compound Thymoquinone Alters Chondrogenic Differentiation of Human Mesenchymal Stem Cells via Modulation of Intracellular Signaling |
| title_short | The Active Compound Thymoquinone Alters Chondrogenic Differentiation of Human Mesenchymal Stem Cells via Modulation of Intracellular Signaling |
| title_sort | active compound thymoquinone alters chondrogenic differentiation of human mesenchymal stem cells via modulation of intracellular signaling |
| topic | human mesenchymal stem cells nf-κ b signalling pathway chondrogenic differentiation thymoquinone |
| url | https://jag.journalagent.com/z4/download_fulltext.asp?pdir=medeniyet&un=MEDJ-68915 |
| work_keys_str_mv | AT banuiskender theactivecompoundthymoquinonealterschondrogenicdifferentiationofhumanmesenchymalstemcellsviamodulationofintracellularsignaling AT banuiskender activecompoundthymoquinonealterschondrogenicdifferentiationofhumanmesenchymalstemcellsviamodulationofintracellularsignaling |